Selene Therapeutics
Epilepsy Therapy
StartupSelene Therapeutics is a -based startup in the Health Tech & Life Sciences sector, established in 2020. Epilepsy Therapy. Selene Therapeutics was founded by Inna Slutsky and Neta Pessah. Key investors include Israel Innovation Authority , RMGP Biopharma Investment Fund, FutuRx. The company has 1-10 employees. Core technologies: Biologicals, Molecules.
The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQ
- Last RoundUndisclosed
- Israel Innovation Authority
- RMGP Biopharma Investment Fund
- FutuRx
Inna SlutskyFounder
Neta PessahCSO
What does Selene Therapeutics do?
Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by regulating the neuronal activity set point by reducing the neuronal mean firing rate. Selene aims to develop small molecules for inhibitors of dihydroorotate dehydrogenase, a mitochondrial enzyme located on the inner mitochondrial membrane that participates in several key cellular homeostatic processes. The company is part of the FuturX biotech incubator in Ness Ziona.
Who founded Selene Therapeutics?
Selene Therapeutics was founded in 2020 by Inna Slutsky (Founder), Neta Pessah (CSO).
What sector is Selene Therapeutics in?
Selene Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Selene Therapeutics located?
Selene Therapeutics is based in Ilan Ramon St 2, Ness Ziyyona, Israel.